Do analysts rate SHPH or SEAC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SeaChange International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, SHPH or SEAC?

SeaChange International has higher revenue and earnings than Shuttle Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shuttle Pharmaceuticals N/A N/A -$11.72M -$47.70 N/A SeaChange International $32.76M 0.27 -$11.40M N/A N/A

Is SHPH or SEAC more profitable?

SeaChange International's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Shuttle Pharmaceuticals N/A -408.34% -138.15% SeaChange International N/A N/A N/A

Do analysts rate SHPH or TAOP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Taoping 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, SHPH or TAOP?

Taoping has higher revenue and earnings than Shuttle Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shuttle Pharmaceuticals N/A N/A -$11.72M -$47.70 N/A Taoping $30.82M 0.25 -$10.06M N/A N/A

Is SHPH or TAOP more profitable?

Taoping's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Shuttle Pharmaceuticals N/A -408.34% -138.15% Taoping N/A N/A N/A

Does the media prefer SHPH or TAOP?

In the previous week, Shuttle Pharmaceuticals had 2 more articles in the media than Taoping. MarketBeat recorded 3 mentions for Shuttle Pharmaceuticals and 1 mentions for Taoping. Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled Taoping'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shuttle Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Taoping 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SHPH or MTBLY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Moatable 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend SHPH or SVRE?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SaverOne 2014 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher earnings and valuation, SHPH or SVRE?

SaverOne 2014 has higher revenue and earnings than Shuttle Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shuttle Pharmaceuticals N/A N/A -$11.72M -$47.70 N/A SaverOne 2014 $290K 28.40 -$8.55M N/A N/A

Is SHPH or SVRE more profitable?

SaverOne 2014's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Shuttle Pharmaceuticals N/A -408.34% -138.15% SaverOne 2014 N/A N/A N/A

Do analysts prefer VS or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Versus Systems 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is VS or SHPH more profitable?

Versus Systems' return on equity of -70.36% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Versus Systems N/A -70.36% -61.70% Shuttle Pharmaceuticals N/A -408.34% -138.15%

Shuttle Pharmaceuticals (SHPH) Competitors

$3.49 -0.12 (-3.32%)

Closing price 04:00 PM Eastern

Extended Trading

$3.42 -0.07 (-1.98%)

As of 08:00 PM Eastern

Compare

SHPH vs. SEAC, TAOP, MTBLY, SVRE, and VS

Should you buy Shuttle Pharmaceuticals stock or one of its competitors? Shuttle Pharmaceuticals's main competitors and comparable companies include SeaChange International (SEAC), Taoping (TAOP), Moatable (MTBLY), SaverOne 2014 (SVRE), and Versus Systems (VS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Shuttle Pharmaceuticals compare to SeaChange International?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and SeaChange International (NASDAQ:SEAC) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Shuttle Pharmaceuticals has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market. Comparatively, SeaChange International has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market.

In the previous week, Shuttle Pharmaceuticals had 3 more articles in the media than SeaChange International. MarketBeat recorded 3 mentions for Shuttle Pharmaceuticals and 0 mentions for SeaChange International. Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled SeaChange International'saverage media sentiment score.

Company	Overall Sentiment
Shuttle Pharmaceuticals	Neutral
SeaChange International	Neutral

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 0.4% of Shuttle Pharmaceuticals shares are owned by insiders. Comparatively, 3.9% of SeaChange International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SeaChange International's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%
SeaChange International	N/A	N/A	N/A

SeaChange International has higher revenue and earnings than Shuttle Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A
SeaChange International	$32.76M	0.27	-$11.40M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SeaChange International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

SeaChange International beats Shuttle Pharmaceuticals on 6 of the 10 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Taoping?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and Taoping (NASDAQ:TAOP) are both small-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation.

Taoping has higher revenue and earnings than Shuttle Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A
Taoping	$30.82M	0.25	-$10.06M	N/A	N/A

Shuttle Pharmaceuticals has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, Taoping has a beta of 0.36, suggesting that its share price is 64% less volatile than the broader market.

In the previous week, Shuttle Pharmaceuticals had 2 more articles in the media than Taoping. MarketBeat recorded 3 mentions for Shuttle Pharmaceuticals and 1 mentions for Taoping. Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled Taoping'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shuttle Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Taoping	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.0% of Taoping shares are owned by institutional investors. 0.4% of Shuttle Pharmaceuticals shares are owned by company insiders. Comparatively, 45.4% of Taoping shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Taoping	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Taoping's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%
Taoping	N/A	N/A	N/A

Summary

Taoping beats Shuttle Pharmaceuticals on 6 of the 8 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Moatable?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and Moatable (NYSE:MTBLY) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 14.5% of Moatable shares are owned by institutional investors. 0.4% of Shuttle Pharmaceuticals shares are owned by insiders. Comparatively, 42.4% of Moatable shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Moatable's net margin of -1.97%. Moatable's return on equity of -2.47% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%
Moatable	-1.97%	-2.47%	-1.69%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Moatable	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Shuttle Pharmaceuticals had 3 more articles in the media than Moatable. MarketBeat recorded 3 mentions for Shuttle Pharmaceuticals and 0 mentions for Moatable. Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled Moatable'saverage media sentiment score.

Company	Overall Sentiment
Shuttle Pharmaceuticals	Neutral
Moatable	Neutral

Shuttle Pharmaceuticals has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, Moatable has a beta of 9.62, suggesting that its share price is 862% more volatile than the broader market.

Moatable has higher revenue and earnings than Shuttle Pharmaceuticals. Moatable is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A
Moatable	$52.07M	0.17	-$8.99M	-$0.14	N/A

Summary

Moatable beats Shuttle Pharmaceuticals on 8 of the 12 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to SaverOne 2014?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and SaverOne 2014 (NASDAQ:SVRE) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 4.9% of SaverOne 2014 shares are held by institutional investors. 0.4% of Shuttle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SaverOne 2014 has higher revenue and earnings than Shuttle Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A
SaverOne 2014	$290K	28.40	-$8.55M	N/A	N/A

SaverOne 2014's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%
SaverOne 2014	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SaverOne 2014	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Shuttle Pharmaceuticals has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, SaverOne 2014 has a beta of 2.17, suggesting that its share price is 117% more volatile than the broader market.

In the previous week, Shuttle Pharmaceuticals had 3 more articles in the media than SaverOne 2014. MarketBeat recorded 3 mentions for Shuttle Pharmaceuticals and 0 mentions for SaverOne 2014. Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled SaverOne 2014'saverage media sentiment score.

Company	Overall Sentiment
Shuttle Pharmaceuticals	Neutral
SaverOne 2014	Neutral

Summary

SaverOne 2014 beats Shuttle Pharmaceuticals on 7 of the 9 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Versus Systems?

Versus Systems (NASDAQ:VS) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Versus Systems' return on equity of -70.36% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Versus Systems	N/A	-70.36%	-61.70%
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

In the previous week, Shuttle Pharmaceuticals had 3 more articles in the media than Versus Systems. MarketBeat recorded 3 mentions for Shuttle Pharmaceuticals and 0 mentions for Versus Systems. Versus Systems' average media sentiment score of 0.00 equaled Shuttle Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Versus Systems	Neutral
Shuttle Pharmaceuticals	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Versus Systems	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Versus Systems has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market.

Versus Systems has higher revenue and earnings than Shuttle Pharmaceuticals. Versus Systems is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Versus Systems	$2.18M	3.30	-$1.79M	-$0.35	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

60.7% of Versus Systems shares are owned by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 0.2% of Versus Systems shares are owned by insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Versus Systems beats Shuttle Pharmaceuticals on 7 of the 10 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHPH vs. The Competition

Export

Metric	Shuttle Pharmaceuticals	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$2.30M	$15.92B	$29.39B	$12.67B
Dividend Yield	N/A	3.40%	2.74%	8.56%
P/E Ratio	-0.07	138.84	75.39	25.27
Price / Sales	N/A	1,290.75	590.90	93.73
Price / Cash	N/A	48.19	48.29	52.08
Price / Book	0.31	7.36	9.17	6.10
Net Income	-$11.72M	$437.25M	$678.51M	$348.86M
7 Day Performance	-2.79%	-1.26%	-2.06%	-1.69%
1 Month Performance	-8.16%	3.43%	1.71%	3.57%
1 Year Performance	-89.67%	3.51%	184.48%	15.00%

Shuttle Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHPH Shuttle Pharmaceuticals	1.0117 of 5 stars	$3.49 -3.3%	N/A	-89.1%	$2.30M	N/A	N/A	5	News Coverage
SEAC SeaChange International	N/A	$3.27 flat	N/A	-24.6%	$9.18M	$32.76M	N/A	100
TAOP Taoping	0.404 of 5 stars	$0.96 +1.6%	N/A	-73.3%	$9.17M	$30.82M	N/A	80	Upcoming Earnings Gap Up
MTBLY Moatable	N/A	$0.54 -2.6%	N/A	-74.9%	$8.80M	$52.07M	N/A	410	Gap Down
SVRE SaverOne 2014	1.0395 of 5 stars	$2.95 +3.9%	N/A	-92.9%	$8.47M	$290K	N/A	40	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHPH) was last updated on 9/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. SEAC, TAOP, MTBLY, SVRE, and VS

How does Shuttle Pharmaceuticals compare to SeaChange International?

Summary

How does Shuttle Pharmaceuticals compare to Taoping?

Summary

How does Shuttle Pharmaceuticals compare to Moatable?

Summary

How does Shuttle Pharmaceuticals compare to SaverOne 2014?

Summary

How does Shuttle Pharmaceuticals compare to Versus Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. SEAC, TAOP, MTBLY, SVRE, and VS

How does Shuttle Pharmaceuticals compare to SeaChange International?

Which has more risk and volatility, SHPH or SEAC?

Does the media favor SHPH or SEAC?

Do insiders & institutionals believe in SHPH or SEAC?

Is SHPH or SEAC more profitable?

Which has stronger valuation and earnings, SHPH or SEAC?

Do analysts rate SHPH or SEAC?

Summary

How does Shuttle Pharmaceuticals compare to Taoping?

Which has stronger earnings and valuation, SHPH or TAOP?

Which has more volatility & risk, SHPH or TAOP?

Does the media prefer SHPH or TAOP?

Do institutionals & insiders believe in SHPH or TAOP?

Do analysts rate SHPH or TAOP?

Is SHPH or TAOP more profitable?

Summary

How does Shuttle Pharmaceuticals compare to Moatable?

Do insiders & institutionals believe in SHPH or MTBLY?

Is SHPH or MTBLY more profitable?

Do analysts rate SHPH or MTBLY?

Does the media prefer SHPH or MTBLY?

Which has more risk and volatility, SHPH or MTBLY?

Which has better valuation and earnings, SHPH or MTBLY?

Summary

How does Shuttle Pharmaceuticals compare to SaverOne 2014?

Do insiders and institutionals believe in SHPH or SVRE?

Which has higher earnings and valuation, SHPH or SVRE?

Is SHPH or SVRE more profitable?

Do analysts recommend SHPH or SVRE?

Which has more volatility and risk, SHPH or SVRE?

Does the media prefer SHPH or SVRE?

Summary

How does Shuttle Pharmaceuticals compare to Versus Systems?

Is VS or SHPH more profitable?

Does the media refer more to VS or SHPH?

Do analysts prefer VS or SHPH?

Which has more risk & volatility, VS or SHPH?

Which has better earnings and valuation, VS or SHPH?

Do insiders & institutionals hold more shares of VS or SHPH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools